Procter & Gamble has faced several challenges in the recent fiscal year, including share loss particularly in developed markets, competitive pricing pressure, and a noted slowdown in market growth rates. However, the companyâ€™s focus on executing a $10 billion productivity improvement program, the benefits of prior pricing actions, and a robust innovation plan indicate a strategy aimed at recoveries in the short term. While the lowered fiscal year guidance reflects ongoing issues, these corrective measures and plans to address volume declines through promotions and innovation suggest an upward trend in the near future for stock price. 
[1]